The University of Southampton
University of Southampton Institutional Repository

A study of safety & effectiveness of evicel fibrin sealant as an adjunctive hemostat in pediatric surgery

A study of safety & effectiveness of evicel fibrin sealant as an adjunctive hemostat in pediatric surgery
A study of safety & effectiveness of evicel fibrin sealant as an adjunctive hemostat in pediatric surgery
Introduction: data on the use of fibrin sealants to control intraoperative bleeding in children are scarce. Evicel Fibrin Sealant (Ethicon Inc., Raritan, New Jersey, United States) was found safe and effective in clinical trials of adults undergoing various surgery types. We evaluated the safety and efficacy of Evicel versus Surgicel Absorbable Hemostat (Ethicon Inc.) as adjunctive topical hemostats for mild/moderate raw-surface bleeding in pediatric surgery.

Methods: a phase III randomized clinical trial was designed as required by the European Medicines Agency's Evicel Pediatric Investigation Plan: 40 pediatric subjects undergoing abdominal, retroperitoneal, pelvic, or thoracic surgery were randomized to Evicel or Surgicel, to treat intraoperative mild-to-moderate bleeding. Descriptive analyses included time-to-hemostasis and rates of treatment success (4, 7, 10 minutes), intraoperative treatment failure, rebleeding, and thromboembolic events.

Results: forty of 130 screened subjects aged 0.9 to 17 years were randomized 1:1 to Evicel or Surgicel. Surgeries were predominantly open abdominal procedures. The median bleeding area was 4.0 cm2 for Evicel and 1.0 cm2 for Surgicel. The median time-to-hemostasis was 4.0 minutes for both groups. The 4-, 7-, and 10-minute treatment success rates were 80.0% versus 65.0%, 100.0% versus 80.0%, and 95.0% versus 90.0%, whereas treatment failure rates were 5.0% versus 25.0%, for Evicel and Surgicel, respectively. No deaths or thrombotic events occurred. Re-bleeding occurred in 5.0% of Evicel and 10.0% of Surgicel subjects.

Conclusions: in accordance with adult clinical trials, this randomized study supports the safety and efficacy of Evicel for controlling mild-to-moderate surgical bleeding in a broad range of pediatric surgical procedures.


bleeding, fibrin sealant, hemostasis, pediatric surgery, topical hemostat
0939-7248
Kenny, Simon
1ffdf8b5-cf4f-48ac-9d73-44df27027aca
Gabra, Hany
c7aa7452-f01e-4cfd-b25e-3d04a524d083
Hall, Nigel J.
6919e8af-3890-42c1-98a7-c110791957cf
Flageole, Helene
cb14ac1d-6e7e-444f-89c0-1173117eebac
Illie, Bogdan
daeb1014-0027-4fde-875a-9f6c24b45f2e
Barnett, Ellie
bf75ab55-992c-465b-85c7-41c23193f891
Kocharian, Richard
35fb2fb7-9b8b-4db1-a292-f4f368a1c0e4
Sharif, Khalid
2f7bf014-2269-418f-b166-effc92d95696
Kenny, Simon
1ffdf8b5-cf4f-48ac-9d73-44df27027aca
Gabra, Hany
c7aa7452-f01e-4cfd-b25e-3d04a524d083
Hall, Nigel J.
6919e8af-3890-42c1-98a7-c110791957cf
Flageole, Helene
cb14ac1d-6e7e-444f-89c0-1173117eebac
Illie, Bogdan
daeb1014-0027-4fde-875a-9f6c24b45f2e
Barnett, Ellie
bf75ab55-992c-465b-85c7-41c23193f891
Kocharian, Richard
35fb2fb7-9b8b-4db1-a292-f4f368a1c0e4
Sharif, Khalid
2f7bf014-2269-418f-b166-effc92d95696

Kenny, Simon, Gabra, Hany, Hall, Nigel J., Flageole, Helene, Illie, Bogdan, Barnett, Ellie, Kocharian, Richard and Sharif, Khalid (2024) A study of safety & effectiveness of evicel fibrin sealant as an adjunctive hemostat in pediatric surgery. European Journal of Pediatric Surgery. (doi:10.1055/s-0044-1785443).

Record type: Article

Abstract

Introduction: data on the use of fibrin sealants to control intraoperative bleeding in children are scarce. Evicel Fibrin Sealant (Ethicon Inc., Raritan, New Jersey, United States) was found safe and effective in clinical trials of adults undergoing various surgery types. We evaluated the safety and efficacy of Evicel versus Surgicel Absorbable Hemostat (Ethicon Inc.) as adjunctive topical hemostats for mild/moderate raw-surface bleeding in pediatric surgery.

Methods: a phase III randomized clinical trial was designed as required by the European Medicines Agency's Evicel Pediatric Investigation Plan: 40 pediatric subjects undergoing abdominal, retroperitoneal, pelvic, or thoracic surgery were randomized to Evicel or Surgicel, to treat intraoperative mild-to-moderate bleeding. Descriptive analyses included time-to-hemostasis and rates of treatment success (4, 7, 10 minutes), intraoperative treatment failure, rebleeding, and thromboembolic events.

Results: forty of 130 screened subjects aged 0.9 to 17 years were randomized 1:1 to Evicel or Surgicel. Surgeries were predominantly open abdominal procedures. The median bleeding area was 4.0 cm2 for Evicel and 1.0 cm2 for Surgicel. The median time-to-hemostasis was 4.0 minutes for both groups. The 4-, 7-, and 10-minute treatment success rates were 80.0% versus 65.0%, 100.0% versus 80.0%, and 95.0% versus 90.0%, whereas treatment failure rates were 5.0% versus 25.0%, for Evicel and Surgicel, respectively. No deaths or thrombotic events occurred. Re-bleeding occurred in 5.0% of Evicel and 10.0% of Surgicel subjects.

Conclusions: in accordance with adult clinical trials, this randomized study supports the safety and efficacy of Evicel for controlling mild-to-moderate surgical bleeding in a broad range of pediatric surgical procedures.


Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Figure 1.cleaned - Accepted Manuscript
Download (177kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Figure 2.cleaned - Accepted Manuscript
Download (110kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Figure 3.cleaned - Accepted Manuscript
Download (56kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Main Text Document_R1_No Highlights - Accepted Manuscript
Download (141kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Table 1 - Accepted Manuscript
Download (25kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Table 2 - Accepted Manuscript
Download (25kB)
Text
Evicel Pediatric Hemostasis study_Eur J Ped Surgery_Table 3_R1_No highlights - Accepted Manuscript
Download (32kB)
Slideshow
Evicel Pediatric Hemostasis_Eur J Ped Surgery_Figure 1 - Accepted Manuscript
Download (138kB)
Slideshow
Evicel Pediatric Hemostasis_Eur J Ped Surgery_Figure 2 - Accepted Manuscript
Download (179kB)
Slideshow
Evicel Pediatric Hemostasis_Eur J Ped Surgery_Figure 3 - Accepted Manuscript
Download (192kB)
Text
s-0044-1785443 - Version of Record
Download (500kB)

Show all 11 downloads.

More information

Accepted/In Press date: 4 March 2024
e-pub ahead of print date: 29 March 2024
Additional Information: Publisher Copyright: © 2023 Georg Thieme Verlag. All rights reserved.
Keywords: bleeding, fibrin sealant, hemostasis, pediatric surgery, topical hemostat

Identifiers

Local EPrints ID: 489078
URI: http://eprints.soton.ac.uk/id/eprint/489078
ISSN: 0939-7248
PURE UUID: cca4f83d-2551-455c-bb2c-d6ec145939ba
ORCID for Nigel J. Hall: ORCID iD orcid.org/0000-0001-8570-9374

Catalogue record

Date deposited: 12 Apr 2024 16:40
Last modified: 17 Aug 2024 01:44

Export record

Altmetrics

Contributors

Author: Simon Kenny
Author: Hany Gabra
Author: Nigel J. Hall ORCID iD
Author: Helene Flageole
Author: Bogdan Illie
Author: Ellie Barnett
Author: Richard Kocharian
Author: Khalid Sharif

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×